Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18439
Revised: June 19, 2014
Accepted: August 13, 2014
Published online: December 28, 2014
Processing time: 251 Days and 1.1 Hours
AIM: To study the relationship between resilience and quality of life (QOL) in patients with digestive cancer.
METHODS: The resilience of patients was measured prior to treatment, and their psychological distress, fatigue status, and treatment side effects were assessed 3 wk after. Their QOL was measured after their treatment ended. A relationship model of these variables was constructed using path analysis.
RESULTS: Resilience explained 33.2% of the variance in psychological distress, 16.1% of the variance in fatigue, and 1.23% of the variance in side effects. The relationship between resilience and QOL was statistically significant (β = 0.119, t = 4.499, P < 0.001) when psychological distress, fatigue, and side effects were absent from the regression model, whereas the adjusted regression coefficient of resilience was not statistically significant (t = 1.562, P > 0.05) when these variables were added. Psychological distress, together with fatigue and side effects, could explain 52.40% of the variance in QOL (P < 0.05). Physiological distress accounted for 28.94% of the total effect on QOL, fatigue accounted for 33.72%, side effects accounted for 22.53%, and resilience accounted for 14.80%.
CONCLUSION: Resilience is not an independent predictor of QOL in patients with digestive cancer, but it is a main factor influencing psychological distress and side effects.
Core tip: Resilience is an individual’s capacity to maintain their psychological and physical well-being in the face of adversity. Cancer is a disease causing severe psychological distress in patients. Exploring the association between resilience and quality of life (QOL) can help us understand the role of resilience in improving the QOL of cancer patients, as well as providing clinical staff with information on psychological intervention and psychological care programs for cancer patients. Our findings highlight the need to develop strategies that improve resilience in patients with digestive cancer.